References
- Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670–6.
- Geser F, Wenning GK, Seppi K, et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 2006;21:179–86.
- Yabe I, Soma H, Takei A, et al. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J Neurol Sci 2006;249:115–21.
- Uversky VN. Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci 2008;9:507–40.
- Lincoln SJ, Ross OA, Milkovic NM, et al. Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism Relat Disord 2007;13:340–2.
- Ozawa T, Healy DG, Abou-Sleiman PM, et al. The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry 2006;77:464–7.
- Ozawa T, Takano H, Onodera O, et al. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 1999;270:110–2.
- Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009;65:610–4.
- Al-Chalabi A, Durr A, Wood NW, et al. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PloS one 2009;4:e7114.
- Ross OA, Vilarino-Guell C, Wszolek ZK, et al. Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol 2010;67:414–5.
- Yun JY, Lee WW, Lee JY, et al. SNCA variants and multiple system atrophy. Ann Neurol 2010;67:554–5.
- Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94–8.
- Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010;74:97–109.
- Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009;41:1308–12.
- Sun ZF, Xiang XS, Chen Z, et al. Increase of the plasma alpha-synuclein levels in patients with multiple system atrophy. Mov Disord 2014;29(Suppl 3):375–9.
- Hu Y, Tang B, Guo J, et al. Variant in the 3′ region of SNCA associated with Parkinson's disease and serum alpha-synuclein levels. J Neurol 2012;259:497–504.
- Multiple-System Atrophy Research C. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 2013;369:233–44.